ENTPD5 and breast carcinoma: We observed the regulation of ITGA5 by the mutp53/ENTPD5 axis across various clinically relevant cancer types, including pancreatic, lung, and breast cancer and for multiple different p53 missense mutants (Supplemental Fig. 1).